Here is Petemantx’s actual iHub post. There are
Post# of 72440
(Total Views: 685)
Posted On: 08/14/2020 7:43:54 PM
Here is Petemantx’s actual iHub post. There are some significant differences from your version.
“Things are progressing, I am sure, but until the money firms up more Leo is keeping things close to the vest and I like this tactic. No need to be letting possible partners know our plans until they need to be known. Gives Leo a stronger negotiating position IMO.
OM advancement could be based on grants received so things currently could be on hold until Leo has a better idea of which direction he wants to go (partner prior to P3, after P3, or other) This should be a fairly inexpensive trial so IMO Leo will want to do it alone. Results of P3 could cause Leo to decide to take OM commercial alone - always an option as there is no competitor, delivery system very simple, distribution should be easy w/ sachets.
IBD has been mentioned that a P2 was expected in Q3 but then CV put everything on hold so IMO very good chance a P2 will start pretty soon in Q4. Again, I think IPIX does this alone and when very good results come back the value of B-IBD will have skyrocketed and then the time for a partnership may start taking hold. Definitely expect a partner for IBD.
Proctitis thru AS - Leo at the mercy of what AlphaSigma wants to do as to progress - they (AS) may wait to see how the P2 UC trial goes prior to doing their trial
Kevetrin - Again, money is the issue. I am sure leo wants to get the pill tox tests finalized ASAP so we can test the pill on healthy volunteers so pill could be used in complementary tests with current cancer treatments.
Who knows if Leo is thinking of franchising out most all indications and if he would prefer working with one main partner rather than a whole slew of different organizations and cultures.
For years we have only been along for the ride, now IPIX (especially if CV turns out very positive) is squarely in the drivers seat. No need to hurry, things are progressing nicely IMO”
“Things are progressing, I am sure, but until the money firms up more Leo is keeping things close to the vest and I like this tactic. No need to be letting possible partners know our plans until they need to be known. Gives Leo a stronger negotiating position IMO.
OM advancement could be based on grants received so things currently could be on hold until Leo has a better idea of which direction he wants to go (partner prior to P3, after P3, or other) This should be a fairly inexpensive trial so IMO Leo will want to do it alone. Results of P3 could cause Leo to decide to take OM commercial alone - always an option as there is no competitor, delivery system very simple, distribution should be easy w/ sachets.
IBD has been mentioned that a P2 was expected in Q3 but then CV put everything on hold so IMO very good chance a P2 will start pretty soon in Q4. Again, I think IPIX does this alone and when very good results come back the value of B-IBD will have skyrocketed and then the time for a partnership may start taking hold. Definitely expect a partner for IBD.
Proctitis thru AS - Leo at the mercy of what AlphaSigma wants to do as to progress - they (AS) may wait to see how the P2 UC trial goes prior to doing their trial
Kevetrin - Again, money is the issue. I am sure leo wants to get the pill tox tests finalized ASAP so we can test the pill on healthy volunteers so pill could be used in complementary tests with current cancer treatments.
Who knows if Leo is thinking of franchising out most all indications and if he would prefer working with one main partner rather than a whole slew of different organizations and cultures.
For years we have only been along for the ride, now IPIX (especially if CV turns out very positive) is squarely in the drivers seat. No need to hurry, things are progressing nicely IMO”
(5)
(1)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼